Content about Neuroendocrine tumor

May 23, 2011
Sutent OKed as pancreatic NET treatment

The Food and Drug Administration has approved a Pfizer drug for treating pancreatic tumors.

May 6, 2011
Novartis' Afinitor approved as advanced pancreatic NET treatment

The Food and Drug Administration has approved a drug made by Novartis as the first treatment for advanced pancreatic neuroendocrine tumors, Novartis said Thursday.

April 13, 2011
FDA advisory committee recommends approval for Pfizer's Sutent

A Food and Drug Administration expert panel has given a favorable vote to a drug made by Pfizer for tumors, Pfizer said Tuesday.

© 2013 Drug Store News. All Rights Reserved.